{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-011915","form_type":"8-K","ticker":"BCDA","cik":"0000925741","company_name":"BioCardia, Inc.","filed_at":"2023-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.886557+00:00","generated_at":"2026-06-16T05:57:54.010658+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BioCardia board adopts amended and restated bylaws for advance notice and technical updates","bullets":["Amended bylaws update advance notice procedures for director nominations and stockholder proposals.","Changes align with current SEC rules and recent amendments to the Delaware General Corporation Law.","Bylaws also include technical, modernizing, and clarifying changes effective April 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-011915","json":"https://secwatch.observer/filing/0001437749-23-011915.json","markdown":"https://secwatch.observer/filing/0001437749-23-011915.md","text":"https://secwatch.observer/filing/0001437749-23-011915.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/0001437749-23-011915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/bcda20230425d_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T05:57:54.010658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c86db9479f3cb5c022149793b575bb351f603dfa","claim":"BioCardia, Inc.: Amended and restated bylaws to update advance notice procedures for director nominations and stockholder business proposals, align with SEC rules and Delaware law, and include technical changes (effective 2023-04-30).","evidence_excerpt":"On April 30, 2023, the board of directors (the “Board”) of BioCardia, Inc. (the “Company”), acting upon the recommendation of the Board’s Nominating and Corporate Governance Committee, approved and adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/0001437749-23-011915-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-04-30"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}